Citation Impact
Citing Papers
Photoswitchable nanoparticles for in vivo cancer chemotherapy
2013
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019
10 Years Experience of the Dermatology Life Quality Index (DLQI)
2004 Standout
Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.
2001
Generation of Human Melanocytes from Induced Pluripotent Stem Cells
2011 StandoutNobel
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds
2008 Standout
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2015
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
2020
Marine natural products
1990 Standout
Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR )
2019
ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice
2016
Randomized Double-blind Trial of Treatment of Vitiligo
2007
Use of the Q-Switched 755-nm Alexandrite Laser to Treat Recalcitrant Pigment after Depigmentation Therapy for Vitiligo
2004
Psoriasis
2021 Standout
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2017
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Chemical and Instrumental Approaches to Treat Hyperpigmentation
2003 Standout
Autologous Cultured Melanocytes in Vitiligo Treatment
2007
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
The behaviour and ecology of the zebrafish,Danio rerio
2007 Standout
Treatment of melasma: a review with personal experience
1998
Quality of Life and Stigmatization Profile in a Cohort of Vitiligo Patients and Effect of the Use of Camouflage
2005
Vitiligo
2015
The Children's Dermatology Life Quality Index: validation of the cartoon version
2003
Surgical Techniques for Vitiligo: A Review
2001
Hidradenitis suppurativa
2020 Standout
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
2006
Narrow‐band UVB311 nm vs. broad‐band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo
2004
Psoriasis
2016
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
2018
Narrow‐band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo
2006
Molecular docking studies of a phlorotannin, dieckol isolated from Ecklonia cava with tyrosinase inhibitory activity
2011
Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life
2006
Atopic dermatitis is associated with a decrement in health‐related quality of life
2002
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
2015 Standout
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
2014
Copper Active Sites in Biology
2014 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Plasma medicine: an introductory review
2009 Standout
An Updated Review of Tyrosinase Inhibitors
2009 Standout
FROM ZEBRAFISH TO HUMAN : Modular Medical Models
2002
4,4′-Dihydroxybiphenyl as a New Potent Tyrosinase Inhibitor
2005
Quality of life in vitiligo patients after treatment with long‐term narrowband ultraviolet B phototherapy
2004
Works of M.D. Njoo being referenced
The Development of Guidelines for the Treatment of Vitiligo
1999
A Systematic Review of Autologous Transplantation Methods in Vitiligo
1998
Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser
2000
Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy☆, ☆☆
2000
Nonsurgical Repigmentation Therapies in Vitiligo
1998
Vitiligo
2001
Association of the Köbner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris
1999
Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands
1999
N-acetylcysteine as a bleaching agent in the treatment of melasma
1997
‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
2014
N‐Acetylcysteine as a bleaching agent in the treatment of melasma
1997
Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort
2016
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t
2016
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
2018
Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature.
1998